Hair depigmentation during chemotherapy with dasatinib, a dual Bcr-Abl/Src family tyrosine kinase inhibitor.(CASE REPORTS)(Report): An article from: Journal of Drugs in Dermatology Customer reviews
Hair depigmentation during chemotherapy with dasatinib, a dual Bcr-Abl/Src family tyrosine kinase inhibitor.(CASE REPORTS)(Report): An article from: Journal of Drugs in Dermatology Overview
This digital document is an article from Journal of Drugs in Dermatology, published by Journal of Drugs in Dermatology, Inc. on April 1, 2009. The length of the article is 2520 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser.
Citation Details
Title: Hair depigmentation during chemotherapy with dasatinib, a dual Bcr-Abl/Src family tyrosine kinase inhibitor.(CASE REPORTS)(Report)
Author: Angel Sun
Publication:Journal of Drugs in Dermatology (Magazine/Journal)
Date: April 1, 2009
Publisher: Journal of Drugs in Dermatology, Inc.
Volume: 8 Issue: 4 Page: 395(4)
Article Type: Report
Distributed by Gale, a part of Cengage Learning
If you want to buy Hair depigmentation during chemotherapy with dasatinib, a dual Bcr-Abl/Src family tyrosine kinase inhibitor.(CASE REPORTS)(Report): An article from: Journal of Drugs in Dermatology CHEAP and FREE shipping Check HERE
Available for download now
Related Products
Customer Reviews
*** Product Information and Prices Stored: Mar 01, 2011 17:45:44
See Also : Camera telephoto lens Discount camera telephoto lens
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.